Supplementary Information and Data from the Combination of Vemurafenib and Procaspase-3 Activation is Synergistic in Mutant BRAF Melanomas
crossref(2023)
摘要
The supplementary information file contains details about primers used for this work, supplementary Figures S1-S8, supplementary Table S1, and results from cell line authentication and from mycoplasma testing.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要